Skip to Main Content

Paper Details

Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets.
Front Immunol
1
2022
Brain-Infiltrating Adaptive Immune Cells, CD45, CD45 cells, Gemcitabine, Group 3 Medulloblastoma, Iba1, Medulloblastoma, Medulloblastomas, Mouse, Myeloid Cells, T and B cells, childhood brain cancer, cyclophosphamide, gemcitabine, immune cells, immune populations, infiltrating, macrophages, medulloblastoma, medulloblastomas, mice, microglia, mouse, neutrophils, tumor
Author NameAffiliation
Robert J Wechsler-ReyaNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Robert J Wechsler-ReyaNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Nicholas G GottardoUniversity of Western Australia
Nicholas G GottardoTelethon Kids Cancer Centre, Telethon Kids Institute
Nicholas G GottardoPerth Children's Hospital
  • 1 - 5

Datasets

Release 1.2